Metropolis Healthcare Limited (NSE:METROPOLIS)
India · Delayed Price · Currency is INR 529.50
-12.00 (-2.22%)
Jun 3, 2026, 11:50 AM IST
Metropolis Healthcare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 16,458 | 13,312 | 12,077 | 11,482 | 12,283 | |
Revenue Growth (YoY) | 23.64% | 10.22% | 5.18% | -6.52% | 23.08% |
Cost of Revenue | 3,245 | 3,030 | 2,699 | 2,741 | 2,976 |
Gross Profit | 13,213 | 10,282 | 9,378 | 8,742 | 9,307 |
Selling, General & Admin | 3,774 | 4,798 | 4,138 | 3,730 | 3,649 |
Research & Development | 230.05 | 102 | 135.77 | 65.71 | 69.07 |
Other Operating Expenses | 5,201 | 2,339 | 2,209 | 2,017 | 2,140 |
Operating Expenses | 10,542 | 8,326 | 7,427 | 6,704 | 6,491 |
Operating Income | 2,671 | 1,956 | 1,951 | 2,037 | 2,817 |
Interest Expense | -245.44 | -185.75 | -225.36 | -268.01 | -197.42 |
Interest & Investment Income | - | 58.48 | 69.1 | 102.3 | 111.48 |
Currency Exchange Gain (Loss) | - | -13.22 | -59.57 | -1.84 | -6.11 |
Other Non Operating Income (Expenses) | 255.85 | - | - | -0 | 48.02 |
EBT Excluding Unusual Items | 2,682 | 1,816 | 1,735 | 1,870 | 2,773 |
Impairment of Goodwill | - | - | - | - | -1.88 |
Gain (Loss) on Sale of Investments | - | 75.06 | 11.56 | 6.78 | 4.26 |
Gain (Loss) on Sale of Assets | - | 17.59 | - | 0.08 | -0.16 |
Asset Writedown | - | - | - | -1.35 | -0.34 |
Other Unusual Items | -89.9 | - | - | - | 159.02 |
Pretax Income | 2,592 | 1,909 | 1,747 | 1,875 | 2,934 |
Income Tax Expense | 679.94 | 453.39 | 462.33 | 441.09 | 786.65 |
Earnings From Continuing Operations | 1,912 | 1,455 | 1,285 | 1,434 | 2,147 |
Minority Interest in Earnings | -11.65 | -5.46 | -6.39 | -5.11 | -5.04 |
Net Income | 1,900 | 1,450 | 1,278 | 1,429 | 2,142 |
Net Income to Common | 1,900 | 1,450 | 1,278 | 1,429 | 2,142 |
Net Income Growth | 31.08% | 13.42% | -10.54% | -33.29% | 16.98% |
Shares Outstanding (Basic) | 207 | 205 | 205 | 205 | 205 |
Shares Outstanding (Diluted) | 207 | 206 | 206 | 205 | 206 |
Shares Change (YoY) | 0.39% | 0.19% | 0.05% | -0.09% | 0.49% |
EPS (Basic) | 9.19 | 7.07 | 6.24 | 6.98 | 10.47 |
EPS (Diluted) | 9.19 | 7.04 | 6.22 | 6.95 | 10.41 |
EPS Growth | 30.59% | 13.19% | -10.57% | -33.25% | 16.40% |
Free Cash Flow | 3,072 | 2,193 | 2,003 | 1,945 | 2,226 |
Free Cash Flow Per Share | 14.86 | 10.65 | 9.74 | 9.46 | 10.82 |
Dividend Per Share | 2.000 | - | 1.000 | 2.000 | 2.000 |
Dividend Growth | - | - | -50.00% | - | - |
Gross Margin | 80.28% | 77.24% | 77.65% | 76.13% | 75.77% |
Operating Margin | 16.23% | 14.70% | 16.16% | 17.74% | 22.93% |
Profit Margin | 11.54% | 10.89% | 10.58% | 12.44% | 17.44% |
Free Cash Flow Margin | 18.67% | 16.48% | 16.59% | 16.94% | 18.12% |
EBITDA | 4,008 | 2,161 | 2,176 | 2,356 | 3,067 |
EBITDA Margin | 24.36% | 16.23% | 18.02% | 20.52% | 24.97% |
D&A For EBITDA | 1,337 | 204.24 | 224.79 | 318.6 | 250.63 |
EBIT | 2,671 | 1,956 | 1,951 | 2,037 | 2,817 |
EBIT Margin | 16.23% | 14.70% | 16.16% | 17.74% | 22.93% |
Effective Tax Rate | 26.24% | 23.76% | 26.47% | 23.52% | 26.82% |
Revenue as Reported | 16,714 | 13,463 | 12,168 | 11,634 | 12,460 |
Advertising Expenses | - | 379.48 | 327.74 | 261.56 | 260.32 |